Skip to main content

Novavax slashes sales guidance in half, stock plunges 30%

Novavax Inc. executives slashed their annual sales guidance in half on Monday while wildly missing financial expectations, sending shares down more than 30% in after-hours trading.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.